Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.

For decades, HSBC, one of the world's largest banks, laundered hundreds of millions of dollars for Mexican drug cartels. Senator Elizabeth Warren, dogged journalists and prosecutors try to hold the bankers to account.

In Canada, maple syrup is worth more than oil. When $20 million of syrup goes missing, the trail leads back to an epic battle between cartels and the little guy.

In 1983 Hasbro bought the license of the Diaclone and Micro Change toys from Takara, then commissioned Marvel Comics to come up with a story-line and character names for the toys. The result: Transformers. Despite Tonka releasing the cheaper Gobots line six months earlier, Hasbro's Transformers took the toy market by storm in 1984, raking in US$150 million that year. At the peak of the toy line's popularity, The Transformers: The Movie hit theaters to further capitalize on its success, but the film polarized fans and collectors with the death of Optimus Prime and majority of the original characters. As Hasbro took full control of Transformers from Takara by the late 1980s, sales declined until the toy line was discontinued in 1991. After the failed Generation 2 reboot, Beast Wars rejuvenated the franchise in 1995.
In 2007, the live-action Transformers film solidified Transformers' position as Hasbro's flagship toy line.

Cooking shows turned the humble garlic bulb into something that's essential to cuisines and into a multi-billion-dollar crop. Every year, humans consume nearly 50 billion pounds of garlic, and most of it comes from one country: China. But a lawsuit raises troubling questions about suppliers.

In the last 50 years, we have doubled the amount of fish we consume. Globally, billions of people rely on seafood as their primary source of protein. But the oceans can't keep up with so much demand. Around the world, fish stocks have plummeted and fisheries are crashing. People lost out. There was an industry just completely ravaged.
As the global fish supply dwindles, the industry faces a crisis on all sides - including crooked moguls, dubious imports and divisive regulations.